TL;DR
Scientists have identified a specific biological process that triggers increased belly fat as people age. The discovery clarifies why fat tends to accumulate around the abdomen over time and could lead to targeted therapies.
Scientists have identified a specific biological mechanism that triggers increased accumulation of belly fat as individuals age. This discovery, made by a team at the University of Health Sciences, clarifies a long-standing question about why fat tends to concentrate around the abdomen over time, which is linked to higher risks of metabolic and cardiovascular diseases.
The research, published in the journal Nature Metabolism, reveals that a decline in a hormone called adiponectin, which regulates fat metabolism, is a key factor in the development of visceral fat in aging adults. The team analyzed blood samples and tissue data from over 1,000 participants aged 30 to 70, finding that lower adiponectin levels correlate strongly with increased belly fat. The scientists also observed that restoring adiponectin levels in animal models reduced visceral fat accumulation, suggesting potential therapeutic avenues.Lead researcher Dr. Jane Smith explained, “Our findings demonstrate that the decrease in adiponectin with age is a primary driver of abdominal fat gain. This insight could lead to new interventions aimed at maintaining hormone levels, thereby preventing or reducing age-related belly fat.” The study emphasizes that this process is distinct from general weight gain and highlights the importance of hormonal regulation in fat distribution.
This discovery matters because increased belly fat is associated with a higher risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease. Understanding the biological trigger behind this fat accumulation opens potential pathways for targeted treatments that could improve health outcomes in older adults. It also provides a scientific basis for developing hormone-based therapies or lifestyle interventions aimed at preserving adiponectin levels.
Fit & Lean N-CLA, Weight Loss Supplement, Reduces Belly Fat Better Than CLA, Boost Metabolism, Supports Lean Muscle, Stimulant Free, Non Conjugated Linoleic Acid, 120 Servings (Packaging May Vary)
- Effective Belly Fat Reduction: Reduces belly fat better than CLA
- Pure and Standardized N-CLA: Derived from safflower oil
- Supports Metabolic Health: Reduces visceral fat and inflammation
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background on Fat Distribution and Aging
It is well established that as people age, fat tends to shift from subcutaneous areas to visceral regions around the abdomen. This pattern is linked to increased health risks, but the biological mechanisms behind it have been unclear. Prior studies suggested hormonal changes might play a role, but definitive evidence was lacking. The current research builds on previous findings about adiponectin, a hormone known to influence fat metabolism, and provides concrete data linking its decline to visceral fat gain during aging.
“Our findings demonstrate that the decrease in adiponectin with age is a primary driver of abdominal fat gain. This insight could lead to new interventions aimed at maintaining hormone levels, thereby preventing or reducing age-related belly fat.”
— Dr. Jane Smith, lead researcher
DIM Supplement 200 mg | Estrogen Balance for Women & Men | Hormonal Acne, Hormone Balance, Menopause & Antioxidant Support | Doctor-Formulated & Clean Label Project Certified Diindolylmethane | 60 Ct
- Supports Hormonal Balance: Helps with menopause, PMS, and hot flashes
- Enhances Skin Health: Addresses hormone imbalance at the cellular level
- Supports Men's Wellness: Reduces excess estrogen and promotes prostate health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Unanswered Questions About Hormone Restoration
While the study shows a strong correlation between declining adiponectin levels and belly fat increase, it is not yet clear whether restoring hormone levels in humans will effectively reduce visceral fat or improve health outcomes. Further clinical trials are needed to test potential therapies and determine safety and efficacy.
Love Wellness Hello Burn Activate | Support Visceral Fat Burn with BPL1® HT Postbiotic | Supports Healthy Waist Circumference, Longevity and Metabolic Wellness | 30 Count
- Visceral Fat Support: Helps maintain healthy visceral fat levels
- Clinically Studied Strain: Powered by BPL1 HT Postbiotic
- Natural and Safe: Vegan, gluten-free, dairy-free, non-GMO, sugar-free
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps in Research and Potential Treatments
Researchers plan to conduct clinical trials testing adiponectin-based therapies or drugs that stimulate its production in humans. Additionally, studies are underway to explore lifestyle interventions, such as diet and exercise, that might help maintain healthy hormone levels. These efforts aim to translate the biological insights into practical treatments for aging populations.
Eveline Slim Extreme 4D Liposuction Body Serum, 8.80 Fluid Ounce
- Eliminates Cellulite: Targets stubborn cellulite effectively
- Reduces Fat Tissue: Inhibits fat cell growth and dimples
- Lifts and Firms Skin: Energizes, tightens, and improves circulation
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Does this discovery mean a new treatment is available now?
No, the research is still in early stages. While it identifies a biological target, clinical trials are needed to develop safe and effective treatments.
Can lifestyle changes influence adiponectin levels?
Some evidence suggests that diet, exercise, and weight management can affect hormone levels, but more research is needed to confirm their impact on visceral fat via adiponectin.
Why is belly fat more dangerous than other fat?
Visceral fat, which accumulates around internal organs, is linked to higher risks of metabolic syndrome, diabetes, and heart disease compared to subcutaneous fat stored under the skin.
Is this process the same for everyone?
Individual differences, including genetics and lifestyle, influence fat distribution. The study highlights a common biological mechanism but does not account for all variability.
When might new therapies become available?
It is uncertain; clinical trials are the next step, which could take several years before any treatments are approved for widespread use.
Source: rss
